Member Info for shan

Inflation concerns swirling
Just have to wait for all that to settle
Nex is certainly safe investment compared to other sectors I feel

plenty of news due but i guess timing is out of SNGs hands...cant just simply speed up results!
either how..im expecting USA fda to make first move ahead of UK

my views on this government are clear for all
i think we could have had a better run had it been labour
the conservatives have spent the last 10 years under-funding the NHS - they wont agree to SNGs price of treatment - more hope in USA

Back in NEX today - cashed up and solid company with a critical/essential service.
atb all and hope everyone safe and well

Clearly a lot of focus on reopening so can maybe see continued declines but stockpiling and future strains will be the calling for sng
Just have to let the trials play out

pmh

do you know i the european union does something similar to fda fast track designation?
that would also cause significant ripples!

fda fast track arrangement!
could come any time really - although granted p3 results will probably be later in summer i think september results

thanks mate
i will sell lol!!

https://www.reuters.com/article/us-health-birdflu-russia/russia-registers-first-case-of-people-infected-with-bird-flu-tass-idUSKBN2AK0DU

it is the dangers of AIM and for that matter wider stock investing - expecting an RNS every day!
There is only so much a company can rns!

Yo Elon Musk......just send a tweet out about SNG and it fly high to around £20!

Tocilizumab is an immunosuppressant! hardly ideal for covid patients!

i have alluded to my clinical background in the past without giving too much away but tocilizumab or simply "Toc" as we call it in ITU is also an immunosuppressant which is not ideal for covid patients!
wont add much more else as not needed!

https://www.google.co.uk/amp/s/www.defenceweb.co.za/featured/sandf-defends-acquisition-of-interferon-drug-from-cuba/amp/

“ “Over the last four months a lot has been reported and written about the Interferon alfa-2b or the Heberon alfa R, since the South African National Defence Force acquired the medication from Cuba on emergency basis following the outbreak of COVID-19 in March 2020. There has since been a great interest in the drug and its efficacy as an immune-modulator in mitigation of COVID-19 complications including death and need for hospitalisation,” the statement read.”

Harchris/Wayne
Just my take but I think most likely institutions who take their set percentages and move on

This is still an AIM company remember
Having said that some serious buyers around so give and take!

"The White House said Joe Biden has been briefed about the recent outbreak of Ebola in west and central Africa.

“While the world is reeling from the ongoing COVID-19 pandemic, Ebola has again emerged, simultaneously, in both Central and West Africa,” White House press secretary Jen Psaki said in a statement.

“The world cannot afford to turn the other way. We must do everything in our power to respond quickly, effectively, and with commensurate resources to stop these outbreaks before they become largescale epidemics.”

https://jvi.asm.org/content/77/14/7945#:~:text=The%20Ebola%20virus%20VP35%20protein%20was%20previously%20found%20to%20act,virus%20IFN%20antagonist%20protein%2C%20NS1.
The Ebola virus VP35 protein was previously found to act as an interferon (IFN) antagonist which could complement growth of influenza delNS1 virus, a mutant influenza virus lacking the influenza virus IFN antagonist protein, NS1.

https://www.sciencedaily.com/releases/2017/03/170321092637.htm
"A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival."

Just checking in...insane amount of huge buys going through and clearing big sellers along the way - nice foundations being laid at every level which bodes well for share price stability.
Chart also looking good...

atb all and please stay safe

true
but its unlikely that EVERY patient is on placebo!
evidence building nicely of anecdotal evidence and patients recovering is extremely good sign

atb all

great news
anecdotal evidence building nicely

its says estimated primary completion date is june 2021
and study completion date is september 2021 - im assuming that's results release date.
feel fda approval could come before that however

exactly!
after all that panic...down 1%!

(ps..speaking on the front lines in ITU - this pandemic is far from over but u already know that)